Buzz on the discussion boards when it comes to Medexus and a series of debentures expiring next year, has not been positive, but is there any basis for real concern, or is this a tempest in a teapot, nothing more than the normal course of business.

Equity Guru founder, Chris Parry, sits down with Medexus director and CEO, Ken d’Entremont to get the skinny on the company’s debenture situation, what plans are forming to deal with them and whether investors be alarmed.

Enjoy!